Received for publication August 23, RESULTS AND DISCUSSION substances. Commercial neomycin which is commonly
|
|
- Joshua Conley
- 5 years ago
- Views:
Transcription
1 A CORRELATION BETWEEN THE STRUCTURE OF AND ITS ACTION ON BACTERIA OLDRICH K. SEBEK Research Laboratories, The Upjohn Company, Kalamazoo, Michigan Received for publication August 23, 1957 Streptomyces fradiae is known to synthesize a tance at 660 m,u (Coleman Junior spectrophotometer). mixture of antibiotics of which two, neomycin B (Regna and Murphy, 1950) and neomycin C (Dutcher et al., 1951), are isomeric antibacterial RESULTS AND DISCUSSION substances. Commercial neomycin which is commonly used in therapeutic treatments is preman and Lechevalier, 1949), chemical work re- Following the discovery of neomycin (Waksdominantly neomycin B. Its growth inhibitory vealed that this antibiotic contained two closely effect, both alone and in combinations with related antibacterial substances, neomycin B various other compounds on different microorganisms, has been extensively investigated. On (Dutcher et al., 1951). In spite of such close (Regna and Murphy, 1950) and neomycin C the other hand, the antibacterial effect of neomycin C has been studied very little. In an atcept of biological specificity suggested that bac- chemical similarity of these two agents, the contempt to obtain more information on the functional relationship of these two antibiotics, their inhibited only by one but not the other neomycin. teria might exist in nature whose growth would be effect on bacterial growth was investigated and If this supposition were indeed found to be correct, such a property could logically be associated preliminary results surmmarized (Sebek, 1955a). The data which are reported here in some detail with those parts of the respective neomycin which demonstrate the differences in the growth-inhibitory characteristics of these agents. In the In an attempt to find organisms which would are structurally different. case of at least two bacterial species, it was possible to identify a chemically defined part of the bacterial species to neomycin B and C were possess such a specificity, the responses of 24 neomycin B molecule as the site of a specific determined. For comparison, neamine-a substance chemically related to the neomycins-was growth inhibitory effect. also included (table 1). MATERIALS AND METHODS The results of this survey indicated that: Preparations of neomycin B, C, and neamine (a) With the exception of Alcaligenes faecalis, used were those reported by Ford et al. (1955). whose growth was not affected even at the 5,000 In the growth-inhibitory experiments, each antibiotic was dissolved in 0.1 M phosphate buffer the three antibiotics to the same extent. These,ug per ml level, no organism was susceptible to (ph 7.9). The solutions were then serially diluted observations corroborated the previously published data of Hamre et at. (1952); (b) In most in 1-ml volumes so that each dilution in the series was twice the preceding one. To these volumes, cases, neomycin B possessed a higher antibacterial 4-ml portions of brain heart infusion broth activity than either neomycin C or neamine; and (Difco), which had been inoculated with the organism under investigation, were added. The (referred to as a coccobacterium by Sebek, 1955a) (c) Two bacteria, namely Corynebacterium sp. tubes were then incubated at 37 C for 2 days. and Sarcina lutea, exhibited unusually different After that period, a record was made of the responses t. the antibiotics. While the growth of highest concentration of each antibiotic at which these two organisms was inhibited by approximately 250,ig of neomycin C or neamine per ml, the organisms were still able to grow (the maximum tolerated concentration, MTC). In order to only ,ug of neomycin B per ml was needed relate bacterial growth to concentration of the to bring about the same effect. Table 1 also shows antibiotic, the amount of the 2-day bacterial similarly specific but less pronounced responses of mass was measured in terms of the light transmit- Micrococcus lysodeikticus to these agents. 199
2 200 SEBEK [VOL. 75 TABLE 1 Responses of bacteria to neomycin B, neomycin C, and neamine A two-day incubation at 37 C in 5 ml of brain heart infusion broth (Difco) Organism Maximum Tolerated Concentration (pug/ml) Neomycin B Neomycin C Neamine Serratia marcescens, ATCC Micrococcus pyogenes var. albus, ATCC Bacillus brevis* Corynebacterium diphtheroides, ATCC Neisseria catarrhalis, OSU 581t Aerobacter aerogenes, ATCC Klebsiella pneumoniae, ATCC Escherichia coli, ATCC Micrococcus pyogenes var. aureus, ATCC 6538P Shigella dysenteriae, ATCC Salmonella paratyphi, Upjohn Proteus vulgaris, ATCC Salmonella pullorum, MSDH: Shigella paradysenteriae var. sonnei, Upjohn Salmonella schottmuelleri, ATCC > 100 Salmonella hirschfeldii, MSDHt SF >100 Pseudomonas aeruginosa, ATCC >100 > 100 Streptococcus pyogenes, C Streptococcus viridans, Diplococcus pneumoniae, Felton I MSDHt Alcaligenes faecalis, ATCC >100 >100 > 100 Micrococcus lysodeikticus, ATCC >100 Corynebacterium sp.li Sarcina lutea, ATCC * From Dr. T. M. Rivers, Rockefeller Inst., New York, N. Y. t From Dept. of Bacteriology, Ohio State Univ., Columbus, Ohio. t From Dr. Wm. F. Ferguson, Michigan State Dept. of Health, Lansing, Mich. From Dr. J. B. Gunnison, Univ. of Calif., San Francisco, Calif. From Dr. H. R. Prentice, Prentice Clinical Lab., Kalamazoo, Mich. From Dr. B. L. Hutchings, Lederle Laboratories, American Cyanamid Co., Pearl River, N. Y. (Hutchings et al., 1948). Because of such striking responses, this phe. nomenon was investigated in more detail with the corynebacterium and the sarcina. Since the responses of both bacteria to neomycin B and C were practically identical, only the findings obtained with the corynebacterium are here described. The response of this organism to the individual antibiotics is given in figure 1. These data show that 1.5,ug of neomycin B per ml completely suppressed the growth and that 0.2,ug per ml allowed the bacterium to grow with no measurable inhibition. In the case of neomycin C or neamine, however, not even 100,ug of antibiotic per mlwhich was the highest concentration tested-was sufficient to suppress the growth completely. Neomycin B was then combined in varying ratios and increasing concentrations with either neomycin C or neamine, or simultaneously with both of these antibiotics. When the bacterium was incubated in the presence of such mixtures, results were obtained which are summarized graphically in figures 2-4. Figure 2 illustrates the response of the organism to the mixtures of neomycin B with neomycin C, figure 3 to the mixtures of neomycin B with neamine, and figure 4 to
3 19581 CORRELATION BETWEEN STRUCTURE AND ACTION OF 201 il/ / ~ ~~~~~.Z yl x/~~ f ~ ~~~~~~~~~~~~ NEAMINE NEOMYCIN C L mcg ANTIBIOTIC/ml Figure 1. Growth response of Corynebacteriuim sp. to neomvcin B, C, and neamine (a 2-day growth at 37 C) z s 70~ a: w 80 m ', x x ' <T. / + NEOMYCIN C X:.N C y- NEOMYCIN C mcq ANTIBIOTIC /ml Figure 2. Growth response of Corynebacterium sp. to the mixtures of neomycin B and C. The amounts of the antibiotics are expressed in terms of neomycin B only. At each neomycin B level tested, neomycin C was present in ratios varying between 1:0.25 and 1:2 (a 2-day growth at 37 C). several combinations of all three antibiotics. These results show that the inhibitory range of the antibiotic mixtures closely coincided with the inhibitory range of neomycin B, and that neomycin C and neamine had very little growth inhibitory effect at the concentrations used. The relationship between the inhibitory properties and chemical structures of these antibiotics was then further investigated by the crossresistance technique. The basis for this technique lies in the assumption that related antibiotics exert their growth inhibitory action through the same or closely similar groupings in their respective molecules. By this method, presumptive evidence for identity or for a close similarity of unknown antibiotics may also be obtained (Szybalski and Bryson, 1952). J In line with this reasoning, the corynebacterium was made resistant separately to neomycin C, neamine, and neomycin B by a series of transfers in brain heart infusion broth to which increasing amounts of the respective antibiotic were added. At each transfer, the mutant with the most highly developed resistance to one antibiotic was tested for the simultaneous development of resistance to the other two (table 2). The results showed that ' w z 1- ro60 50' X-I... I A A mcg ANTIBIOTIC/ml + NEAMINE NEAMINE 6 12 Figure S. Growth response of Corynebacterium sp. to the mixtures of neomycin B and to neamine. The amounts of the antibiotics are eypressed in terms of neomycin B only. At each neomycin B level tested, neamine was present in ratios varying between 1:0.25 and 1:2 (a 2-day growth at 37 C) NEOMYCIN C,., 80 [/;' + NEAMINE 60- ~ NEAMINE / 60 A NEAMINE NEOMYCIN C Q8 I5 12 mcg ANTIBIOTIC/ml Figure 4. Growth response of Corynebacterium sp. to the mixtures of neomycin B, C, and neamine. The amounts of the antibiotics are expressed in terms of neomycin B only. At each neomycin B level tested, neomycin C and neamine were present in the following ratios: 1:1:1, 1:0.25:0.25, 1:0.25:1, and 1:1:0.25 (a 2-day growth at 37 C).
4 202 SEBEK [VOL. 75 TABLE 2 Resporse to neomycin C, neamine and neomycin B of Corynebacterium sp. and its resistant mutants The organism was grown in the presence of increasing amounts of the specified antibiotic at 37 C. At each transfer the mutants with the most highly developed resistance were tested for the degree of resistance which simultaneously developed to the remaining two antibiotics. Maximum Tolerated Concentration (jig/ml) Developed Resistance Antibiotic Tested Transfer Parent- First Second Third Sixth Neomycin C Neomycin C ,000 Neamine ,000 Neomycin B Neamine Neamine ,000 Neomycin C ,000 Neomycin B Neomycin B Neomycin B Neomycin C Neamine 2E in 6 successive transfers of the bacterium in the presence of neomycin C or neamine, the organism increased its resistance to these antibiotics 100 to 400 times. In both cases this increase in resistance proceeded at similar but not identical rates. This indicated that these two antibiotics did not inhibit the microorganism by an identical mechanism. At the same time, however, the resistance of these mutants to neomycin B increased comparatively little (approximately 12 times). When, on the other hand, the resistance of this organism to neomycin B increased 50 times in 6 successive transfers, the resistance to neomycin C and neamine increased only twice in each instance. Once the organisms acquired a considerably high level of resistance, they retained it rather tenaciously. Thus, the corynebacterium made resistant to 20,000 ug of neomycin C per ml, retained this high resistance after 21 daily transfers in antibiotic-free medium. However, when the organism made resistant to lower levels of neomycin C (1000 to 2000,ug per ml), was subcultured in antibiotic-free medium, it reverted almost completely to its original sensitivity. None of these antibiotics was either destroyed or inactivated, for even after a 5-day incubation with the organism in shaken flasks, their titers remained unchanged when measured by the plate assay method and identified by paper chromatographic means (Sebek, 1955b). Although the organism thrived in the presence of 50,000 jig neomycin C per ml, no destruction of the antibiotic was detected. The specific inhibitory effect of neomycin B on the corynebacterium and sarcina, and the failure of these organisms to develop reciprocal crossresistance to neomycin B and C, indicated that the two antibiotics affected the growth of these bacteria through very different mechanisms. As a corollary, these data also provided biological evidence that neomycin B and C were not identical chemical entities. It is known that these two substances are isomeric and that they have, according to the more recent data, a formula of C23H48N6013 (Ford et al., 1955) or C23H46N6013 (Rinehart et al., 1957a). Upon methanolysis (or hydrolysis with 6 N HCl) both give the same non-reducing base, neamine, C12H26N406 (Leach and Teeters, 1951) which is identical with neomycin A (Peck et al., 1949; Leach and Teeters, 1952). In addition to neamine, the methanolysis of neomycin B yields neobiosamine B (isolated and identified as methyl neobiosaminide B), and neomycin C gives neobiosamine C (also isolated as its methyl glycoside, methyl neobiosaminide C). Neobiosamine B and C were shown to be isomeric diaminohexosido-pentoses (C1uH22N208, Rinehart et al., 1957a). The pentose moiety in both neobiosamines has been isolated and identified as D-ribose (Rinehart et al., 1957b). From this chemical evidence, the composition
5 1958] CORRELATION BETWEEN STRUCTURE AND ACTION OF 203 Neomycin B Neobiosamine B Diaminohexose B Neamine (Neomycin A) D-Ribose Neomycin C Neobiosamine C Diaminohexose C Figure 6. Degradation products of neomycin B and neomycin C. of the neomycin molecule may be written in the following fashion: C12H25N40.-O-C5H60(OH)-O-C6H70(OH)2(NHD2 Neamine D-Ribose Diaminohexose (B or C) It may also be seen that the difference between the neomycin B and C molecules lies only in their respective diaminohexose moieties (figure 5). Since neomycin B, but not neomycin C, was highly inhibitory for the growth of the corynebacterium and the sarcina, it is concluded that it is the diaminohexose portion of neomycin B with its particular configuration or linkages to other parts of the molecule, that is instrumental in the specific inhibition of growth of these two bacteria. Although the inhibition of these two organisms by neomycin B was very pronounced, it was not an isolated phenomenon. The inhibitory levels of this agent for most of the bacteria listed in table 1 were invariably lower than those of neomycin C. This indicates that neomycin B affected these organisms also through its diaminohexose portion.'1 2 Other inhibitory mechanisms could have simultaneously been at play. Observations of this nature may be found in the literature. Thus, Welsch et al. (1954) observed marked differences in the growth inhibitory activity of three closely related antibiotics, chlor- 1 The whole neomycin B molecule is essential for its high growth-inhibitory effect since neither methyl neobiosaminide B alone nor in combination with neamine arrested the growth of these organisms even at 100 ug per ml. 2 Amino sugars have been found in several other antibiotics (e. g., angolamycin, carbomycin, erythromycin, foromacidine, griseomycin, miamycin, narbomycin, picromycin, puromycin, spiramycin, streptomycin). When more chemical data become available, the use of suitable organisms may reveal that these moieties play a specific role in the action of these antimicrobial agents. tetracycline, oxytetracycline and tetracycline, on 338 strains of staphylococci and noted later (Reedy et al., 1955) a similar differential effect on nine additional bacterial genera. Maxwell and Nickel (1954) as well as Hahn et al. (1954) found that D(-)threo chloramphenicol was highly inhibitory for the growth of Escherichia coli and Bacillus subtilis, respectively, while its L( +)- erythro stereoisomer was only slightly bacteriostatic for these bacteria. The latter group of investigators (Hahn et al., 1956) postulated that, in addition to other considerations, the structural features of the chloramphenicol molecule have a specific influence on its antibacterial action. On the other hand, erythromycin and erythromycin B, which are closely related, showed no significant differences in their antibacterial spectra (Grundy et al., 1955). Since, however, the development of resistance to these agents proceeded at different rates, organisms may be found-as evidenced by our observationswhich would be sensitive to only one of the erythromycins. Such exacting organisms might also be useful in detecting specific components in mixtures of closely related antibiotics. ACKNOWLEDGMENTS Grateful acknowledgment is made to Mrs. E. E. Nelson forher able assistance, and to Dr. K. L. Rinehart, Jr., University of Illinois, who provided us with the data on the neomycin chemistry prior to their publication. SUMMARY Growth-inhibitory effect of neomycin B, neomycin C and neamine on twenty-four bacterial species was investigated. Differences in such an effect were found in most of the organisms tested. They were particularly striking in two bacteria, Corynebacterium sp. and Sarcina lutea. The data reported here on the corynebacterium showed that its growth was inhibited by approximately 250,ug of neamine or neomycin C per ml but by only 0.4 to 1.6,ug of neomycin B per ml. The inhibitory concentrations of neomycin B remained practically unchanged even when neomycin C and neamine were added in varying ratios and in different combinations. The organism readily acquired resistance and cross-resistance to neamine and neomycin C to a high degree but only slightly to neomycin B. The data indicate that the diaminohexose portion of neo-
6 204 SEBEK [VOL. 75 mycin B is responsible for the specific growthinhibitory effect of this antibiotic on these two bacteria., REFERENCES DUTCHER, J. D., HOSANSKY, N., DONIN, M. N., AND WINTERSTEINER, Neomycins B and C and some of their degradation products. J. Am. Chem. Soc., 73, FORD, J. H., BERGY, M. E., BROOKS, A. A., GARRErT, E. R., ALBERTI, J., DYER, J. R., AND CARTER, H. E Further characterization of neomycin B and neomycin C. J. Am. Chem. Soc., 77, GRUNDY, W. E., ALFORD, E. F., RICKHER, C. J., BOWER, R. R., RDZOK, E. J., AND SYLVESTER, J. C A microbiological comparison of erythromycin and erythromycin B. Antibiotics & Chemotherapy, 5, HAHN, F. E., WISSERMAN, C. L., JR., AND Hopps, H Mode of action of chloramphenicol. II. Inhibition of bacterial D-polypeptide formation by an L-stereoisomer of chloramphenicol. J. Bacteriol., 67, HAHN, F. E., HAYES, J. E., WISSEMAN, C. L., JR., Hopps, H. E., AND SMADEL, J. E Mode of action of chloramphenicol. VI. Relation between structure and activity in the chloramphenicol series. Antibiotics & Chemotherapy, 6, HAMRE, D. M., PANSY, F. E., LAPEDES, D. N., PERLMAN, D., BAYAN, A. P., AND DoNoVICm, R Some characteristics of the neomycins. Antibiotics & Chemotherapy, 2, HUTCHINGS, B. L., STOKSTAD, E. L. R., BOHONOS, N., SLOANE, N. H., AND SUBBAROW, Y The isolation of the fermentation Lactobacillus casei factor. J. Am. Chem. Soc., 70, 1-3. LEACH, B. E. AND TEETERS, C. M Neamine, an antibacterial degradation product of neomycin. J. Am. Chem. Soc., 73, LEACH, B. E. AND TEETERS, C. M The identity of neamine and neomycin A. J. Am. Chem. Soc., 74, MAXWELL, R. E. AND NICKEL, V. S The antibacterial activity of the isomers of chloramphenicol. Antibiotics & Chemotherapy, 4, PECK, R. L., HOFFHINE, C. E., JR., GALE, P., AND FOLKERS, K Streptomyces antibiotics. XXIII. Isolation of neomycin A. J. Am. Chem. Soc., 71, REEDY, R. J., RANDALL, W. A., AND WELCH, H Variations in the antimicrobial activity of the tetracyclines. II. Antibiotics & Chemotherapy, 5, REGNA, P. AND MURPHY, F. X The isolation of neomycin B. J. Am. Chem. Soc., 72, RINEHART, K. L., JR., WOO, P. W. K., ARGOUDELIS, A. D., AND GIESBRECHT, A. M. 1957a Chemistry of the neomycins. I. A partial structure of neobiosamines B and C. J. Am. Chem. Soc., 79, RINEHART, K. L., JR., WOO, P. W. K., AND ARGOUDELIS, A. D. 1957b Chemistry of the neomycins. II. The pentose moiety. J. Am. Chem. Soc., 79, SEBEK, 0. K. 1955a The differential action of neomycins on bacteria. Bacteriol. Proc., 1955, 78. SEBEK, 0. K. 1955b The synthesis of neomycin- C14 by Streptomyces fradiae. Arch. Biochem. Biophys., 57, SZYBALSKI, W. AND BRYSON, V Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J. Bacteriol., 64, WAKSMAN, S. A. AND LECHEVALIER, H. A Neomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms. Science, 109, WELCH, H., RANDALL, W. A., REEDY, R. J., AND OSWALD, E. J Variations in antimicrobial activity of the tetracyclines. Antibiotics & Chemotherapy, 4,
Rutgers University, New Brunswick, N. J.) All these cultures proved to be highly active against mycobacteria.
NEOMYCIN-PRODUCTION AND ANTIBIOTIC PROPERTIES 1, 2 3 By SELMAN A. WAKSMAN, HUBERT A. LECHEVALIER, AND DALE A. HARRIS (From the Department of Microbiology, New Jersey Agricultural Experiment Station, Rutgers
More informationTOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya
16 THE JOURNAL OF ANTIBIOTICS JAN. 1972 TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya Biological Research Laboratories, Research
More informationPharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE
Pharm 262: 1 Pharmaceutical Microbiology II Antibiotics DR. C. AGYARE Reference Books 2 HUGO, W.B., RUSSELL, A.D. Pharmaceutical Microbiology. 6 th Ed. Malden, MA: Blackwell Science, 1998. WALSH, G. Biopharmaceuticals:
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationThe Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University
The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants
More informationObservations on the Mode of Action of Antibiotic Synergism and Antagonism
Antibiotics and other compounds. The substances tested were : (a) chlortetracycline hydrochloride (aureomycin, Lederle) in freshly prepared solution, and in a form partially inactivated by heating 200
More informationSYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data
508 SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data Physical Properties Active Ingredient: Ethyl Alcohol 62% (70% v/v) Appearance: Clear, Colorless Solution Fragrance: Floral Form:
More information6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS
6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although
More informationGuidelines for Laboratory Verification of Performance of the FilmArray BCID System
Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality standards for all laboratory
More informationQ1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.
Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.
More informationKlett-Summerson photoelectric colorimeter. The presence of the glucose RESISTANCE AND SYNERGISM IN STREPTOMYCIN
THE CORRELATION BETWEEN THE INHIBITION OF DRUG RESISTANCE AND SYNERGISM IN STREPTOMYCIN AND PENICILLIN' MORTON ELEIN AND LEONARD J. KIMMELMAN Department of Bacteriology, School of Medicine, University
More informationIsolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities
International Journal of Microbiology and Allied Sciences (IJOMAS) ISSN: 2382-5537 May 2016, 2(4):22-26 IJOMAS, 2016 Research Article Page: 22-26 Isolation of antibiotic producing Actinomycetes from soil
More informationAntibiotic Resistance in Bacteria
Antibiotic Resistance in Bacteria Electron Micrograph of E. Coli Diseases Caused by Bacteria 1928 1 2 Fleming 3 discovers penicillin the first antibiotic. Some Clinically Important Antibiotics Antibiotic
More informationMicroscopy Directions
Name: Exercise 1 Microscopy Focus each slide of bacteria under the microscope using oil immersion. Draw the arrangement of the bacterial cells in the larger portion of the circle and draw the shape of
More informationA LABORATORY TEST FOR BACTERIAL SENSITIVITY TO COMBINATIONS OF ANTIBIOTICS
A LABORATORY TEST FOR BACTERIAL SENSITIVITY TO COMBINATIONS OF ANTIBIOTICS ERNEST JAWETZ, M.D., PH.D., JANET B. GUNNISON, M.A., VIRGINIA R. COLEMAN, B.A., AND HENRY C. KEMPE, M.D. WITH THE TECHNICAL ASSISTANCE
More informationDrug resistance in relation to use of silver sulphadiazine cream in a burns unit
J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham
More informationBACTERIOLOGY OF THE HEALTHY CONJUNCTIVA*
Brit. J. Ophthal. (1954), 38, 719. BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* BY C. H. SMITH Department of Pathology, Institute of Ophthalmology, University of London THE normal bacterial flora of the mucous
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationInternational Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.
I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE
ANTIMICROBIAL TESTING with ALKA VITA (ALKAHYDROXY ) on ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE FINAL RESULTS OF ANTIBACTERIAL TESTS IN VITRO WITH THE PRODUCT
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationNocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda
Cephamycins Cephamycins Antibiotics III. Cephamycin A-C, 1971, Str. lipmanii 7 -Methoxy group: Somewhat diminished antibacterial activity Resistant to a wide range of ß-lactamase enzymes 3-CH 2 -carbamoyl
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationResistance of Coagulase-Positive Staphylococci
JOURNALOF BACrERIOLOGY, Apr., 1965 Copyright a 1965 American Society for Microbiology Vol. 89, No. 4 Printed in U.S.A. Resistance of Coagulase-Positive Staphylococci to Methicillin and Oxacillin CHARLES
More informationSTANCES. VIII. PRODUCTION OF A GRISEIN-LIKE ANTI-
232 BACTERIOLOGY: GARSON AND WAKSMAN PROC. N. A. S. Two points are of particular interest. The first is the independent confirnation of Lederberg and Tatum's demonstration of regular recombination in E.
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More information4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases
4 th and 5 th generation cephalosporins Naderi HR Associate professor of Infectious Diseases Classification Forth generation: Cefclidine, cefepime (Maxipime),cefluprenam, cefoselis,cefozopran, cefpirome
More informationUSA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only
USA Product Label http://www.vetdepot.com PHARMACIA & UPJOHN COMPANY Division of Pfizer Inc. Distributed by PFIZER INC. 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Fax: 616-833-4077 Customer
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationJAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro
Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry
More informationAntibacterial Agents & Conditions. Stijn van der Veen
Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only
More informationFujio Kobayashi, Takao Nagoya, Yoko Yoshimura, Kuniko Kaneko and Shin-ichi Ogata
128 THE JOURNAL OF ANTIBIOTICS FEB. 1972 STUDIES ON NEW ANTIBIOTIC LIVIDOMYCINS. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY OF LIVIDOMYCIN A Fujio Kobayashi, Takao Nagoya, Yoko Yoshimura, Kuniko Kaneko
More informationIn Vitro Activity of Netilmicin, Gentamicin, and Amikacin
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin
More informationInhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug
More information17June2017. Parampal Deol, Ph.D, MBA Senior Director, R&D Microbiology North America
RAPID DETECTION OF BACTERIAL CONTAMINANTS IN PLATELET COMPONENTS: COMPARISON OF TIME TO DETECTION BETWEEN THE BACT/ALERT 3D AND THE BACT/ALERT VIRTUO SYSTEMS. 17June2017 Parampal Deol, Ph.D, MBA Senior
More informationVOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill
VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin
More informationGeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007
GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure
More informationCleaning and Disinfection Protocol Vegetative Bacteria
Cleaning and Disinfection Protocol Vegetative Bacteria This document has been developed in accordance with current applicable infection control and biosecurity guidelines. It is intended for use as a guideline
More informationDO NOT WRITE ON or THROW AWAY THIS PAPER!
What Kills Bacteria? Lab Procedure Go to the following link: http://www.glencoe.com/sites/common_assets/science/virtual_labs/ls08/ls08.html or DO NOT WRITE ON or THROW AWAY THIS PAPER! Visit my eboard
More informationGENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS
390 CHEMOTHERAPY JULY 1967 GENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS M. OHOKOSHI*, Y. NAIDE, T. KAWAMURA, K. SUZUKI,
More informationCleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria
Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria This document has been developed in accordance with current applicable infection
More informationSusceptibility Testing
APPLIED MICROBIOLOGY, Nov. 1969, p. 766-770 Copyright 1969 American Society for Microbiology Vol. 18, No. 5 Printed in U.S.A. Effect of Mixed Cultures on Antibiotic Susceptibility Testing AZRA SHAHIDI
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationQUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)
Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate
SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin
More informationPREVALENCE OF SUBCLINICAL MASTITIS AND ANTIBIOTIC RESISTANT BACTERIA IN THREE SELECTED CATTLE, FARMS IN SERDANG, SELANGORAND KLUANG, JOHOR
J. Vet. Malaysia (2005) 17 (1): 27-31 PREVALENCE OF SUBCLINICAL MASTITIS AND AIBIOTIC RESISTA BACTERIA IN THREE SELECTED CATTLE, FARMS IN SERDANG, SELANGORAND KLUANG, JOHOR Norlida Othman and A.R. Bahaman
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationCultiControl. Technical Sheet 01
CultiControl Technical Sheet 01 CultiControl freeze-dried microorganisms Packaging: 1 vial containing 5 pellets Non-enumerated CFU Applications: Culture purposes, QC of ID devices, QC of AST devices Quanti-CultiControl
More informationVitek QC Sets. Vitek 2 Identification QC Sets
Vitek 2 Identification QC Sets MicroBioLogics is selling two types of Vitek 2 microorganism identification sets. They are listed below in two columns. The first column lists the 2008 quality control microorganisms
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationMicrobiology ( Bacteriology) sheet # 7
Microbiology ( Bacteriology) sheet # 7 Revision of last lecture : Each type of antimicrobial drug normally targets a specific structure or component of the bacterial cell eg:( cell wall, cell membrane,
More informationAminoglycoside-resistant enterococci
Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY
More informationEXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test
EXPERIMENT Antibiotic Sensitivity-Kirby Bauer Diffusion Test Author Name Version 42-0238-00-02 Review the safety materials and wear goggles when working with chemicals. Read the entire exercise before
More informationPharmacological Evaluation of Amikacin in Neonates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.
More informationAntimicrobial agents
Bacteriology Antimicrobial agents Learning Outcomes: At the end of this lecture, the students should be able to: Identify mechanisms of action of antimicrobial Drugs Know and understand key concepts about
More informationNo-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program
Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationReassessment of the "Class" Concept of Disk Susceptibility Testing
Reassessment of the "Class" Concept of Disk Susceptibility Testing Disks versus Minimal Inhibitory Concentrations with Eleven Cephalosporins ARTHUR L. BARRY, PH.D., CLYDE THORNSBERRY, PH.D., RONALD N.
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationAn effective antibiotic cover for the prevention
J. clin. Path. (1966), 19, 561 An effective antibiotic cover for the prevention of endocarditis following dental and other post-operative bacteraemias1 OMAR KHAIRAT From the Faculties ofmedicine and Dentistry,
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationAntimicrobial Therapy
Chapter 12 The Elements of Chemotherapy Topics - Antimicrobial Therapy - Selective Toxicity - Survey of Antimicrobial Drug - Microbial Drug Resistance - Drug and Host Interaction Antimicrobial Therapy
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oxycare 20 %w/v LA Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Substance: Oxytetracycline (Equivalent
More informationVisit ABLE on the Web at:
This article reprinted from: Lessem, P. B. 2008. The antibiotic resistance phenomenon: Use of minimal inhibitory concentration (MIC) determination for inquiry based experimentation. Pages 357-362, in Tested
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationC&W Three-Year Cumulative Antibiogram January 2013 December 2015
C&W Three-Year Cumulative Antibiogram January 213 December 215 Division of Microbiology, Virology & Infection Control Department of Pathology & Laboratory Medicine Contents Comments and Limitations...
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationMacrolide Resistance in Staphylococcus aureus: Inducers of
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1977, p. 669-674 Copyright 1977 American Society for Microbiology Vol. 11, No. 4 Printed in U.S.A. Macrolide Resistance in Staphylococcus aureus: Inducers of
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationTitle: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationTEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus
TEST REPORT TEST TYPE: Liquid Suspension Time Kill Study -Quantitative Test Based On ASTM 2315 TEST METHOD of Colloidal Silver Product at Contact time points: 30 sec, 1 min, 2 min, 5 min, 10 min, 15 min
More informationTest Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants
Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified
More informationDevelopment of Resistant Bacteria Isolated from Dogs with Otitis Externa or Urinary Tract Infections after Exposure to Enrofloxacin In Vitro
A. M. Brothers, P. S. Gibbs, and R. E. Wooley Development of Resistant Bacteria Isolated from Dogs with Otitis Externa or Urinary Tract Infections after Exposure to Enrofloxacin In Vitro Amy M. Brothers,
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh
ANTIBIOTIC RESISTANCE Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development
More informationEnterobacter aerogenes
Enterobacter aerogenes Enterobacter sp. Enterobacter sp. Species: Enterobacter aerogenes Enterobacter agglomerans Enterobacter cloacae causes UTI, enterotoxigenic Often found in the normal intestinal flora,
More informationFinnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs
PathoProof TM Mastitis PCR Assay Mikko Koskinen, Ph.D. Director, Diagnostics, Finnzymes Oy Real time PCR based mastitis testing in milk monitoring programs PathoProof Mastitis PCR Assay Comparison of the
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationEuropean Public MRL assessment report (EPMAR)
18 March 2016 EMA/CVMP/619817/2015 Committee for Medicinal Products for Veterinary Use European Public MRL assessment report (EPMAR) Gentamicin (all mammalian food producing species and fin fish) On 3
More informationBiochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010
Biochrom AG s antibiotics solutions: Up-to to-date overview regarding of action, performance and working concentration Biochrom AG Information, November 19, 2010 Cell culture media allow not only cells
More informationOzone Inactivation Kinetics of Multiple Antibiotic Resistant Strains of Bacteria in Water.
Ozone Inactivation Kinetics of Multiple Antibiotic Resistant Strains of Bacteria in Water. M. S. Gutiérrez, I. Lezcano, Ch. Baluja and E. Sánchez Centro de Investigaciones del Ozono Calle 230 # 1313 y
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationStudy Type of PCR Primers Identified microorganisms
Study Type of PCR Primers Identified microorganisms Portillo et al, Marín et al, Jacovides et al, Real-time multiplex PCR (SeptiFasta, Roche Diagnostics) 16S rr gene was amplified using conventional PCR.
More informationAntibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut
Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance
More informationGram-positive cocci Staphylococci and Streptococcia
Medical microbiology Laboratory Lab 8 Gram-positive cocci Staphylococci and Streptococcia Lecturer Maysam A Mezher Gram positive cocci 1-Staphylococcus. 2-Streptococcus. 3-Micrococcus The medically important
More informationSusceptibility Pattern of Some Clinical Bacterial Isolates to Selected Antibiotics and Disinfectants
Polish Journal of Microbiology 2008, Vol. 57, No 3, 199 204 ORIGINAL PAPER Susceptibility Pattern of Some Clinical Bacterial Isolates to Selected Antibiotics and Disinfectants JUDE N. OGBULIE, IFECHUKWU
More informationDairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis
Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis EnZtek Diagnostics Incorporated has investigated and successfully
More informationTEST REPORT ON THE ANTIBACTERIAL AND FUNGICIDAL EFFECTS OF THE PRODUCT. Herba Sept
ИНСТИТУТ ЗА БИОЛОШКА ИСТРАЖИВАЊА,,СИНИША СТАНКОВИЋ'' Универзитет у Београду Бул. деспота Стефана 142 Директор: 011-2078-399 Тел: 011-2078-300 Факс: 011-2078-433 www.ibiss.bg.ac.rs Број/ No. 01-318 INSTITUTE
More informationStreptomycin Like Antibiotic from Streptomyces spp. Isolated from Mount Everest Base Camp
Nepal Journal of Science and Technology 9 (2008) 73-77 Streptomycin Like Antibiotic from Streptomyces spp. Isolated from Mount Everest Base Camp Jyotish Yadav 1, Upendra Thapa Shrestha 2, Kiran Babu Tiwari
More informationAre Antibiotics a Concern in Distiller s Co-products?
Are Antibiotics a Concern in Distiller s Co-products? G.C. Shurson 1, D.M. Paulus 1, A. DiCostanzo 1, G.I. Crawford 2, F. Diez- Gonzalez 3, and R.C. Fink 3 1 Department of Animal Science 2 University of
More informationCAUTION Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
LINCOCIN- lincomycin hydrochloride injection, solution Pharmacia and Upjohn Company ---------- Lincocin lincomycin hydrochloride tablets and liquid lincomycin injection, USP For Use in Animals Only For
More information